Kennedy Capital Management, Inc. Charles River Laboratories International, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 80,407 shares of CRL stock, worth $13.3 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
80,407
Previous 107,482
25.19%
Holding current value
$13.3 Million
Previous $22.2 Million
28.66%
% of portfolio
0.37%
Previous 0.51%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
52.1MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$844 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$620 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$353 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$322 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.43B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...